1. Predictive factors for biliary stones after donor brain dead liver transplantation. (2019) Authors: Maggi, U.; Paone, G.; Chierici, A.; Fornoni, G.; Conte, D.; Cantù, P.; Fabbi, M.; Caccamo, L.; Rossi, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Livers from brain dead donors with chronic active alcohol abuse for liver transplantation. (2019) Authors: Maggi, U.; Fabbi, M.; Melada, E.; Fornoni, G.; Antonelli, B.; Rota, R.; Invernizzi, F.; Reggiani, P.; Rossi, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.11.5: Endotherapies for Duct-To-Duct Biliary Anastomotic Stricture after Liver Transplantation (Basalt Study Group): Interim Analysis and Medium-Term Outcomes of a Retrospective Nationwide Italian Survey. (15th March 2017) Authors: Cantù, P.; Parzanese, I.; Rosa, R.; Barbaro, F.; Forti, E.; Lombardi, G.; Nadal, E.; Boarino, V.; Pisani, A.; Di Sario, A.; Bertani, H.; Bulajic, M.; Ghinolfi, D.; Tringali, A.; Costamagna, G.; Mutignani, M.; Fantin, A.; Merighi, A.; Traini, S.; Conigliaro, R. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early recurrence of hepatocellular carcinoma after liver transplantation can be predicted by fdg-pet and microvascular invasion at explant pathology. (February 2020) Authors: Iavarone, M.; Invernizzi, F.; Dondossola, D.; De Monti, A.; Mazza, S.; Maggi, U.; Antonelli, B.; De Feo, T.; Florimonte, L.; Lampertico, P.; Rossi, G.; Donato, M.F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival. (February 2019) Authors: Mazza, S.; Invernizzi, F.; Iavarone, M.; Zavaglia, C.; Maggi, U.; Cesarini, L.; Antonelli, B.; Airoldi, A.; Manini, M.A.; Sangiovanni, A.; Rossi, G.; Donato, M.F.; Belli, L.S.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival. Issue 1 (February 2018) Authors: Invernizzi, F.; Iavarone, M.; Donato, M.F.; Sangiovanni, A.; Monico, S.; Manini, M.A.; Maggi, U.; Antonelli, B.; Dondossola, D.; Rossi, G.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Highlights on biliary complications in 390 cadaveric liver transplantations in adults, over a 10 years period. (April 2016) Authors: Maggi, U.; Chierici, A.; Lauro, R.; Paone, G.; Zampini, D.; Reggiani, P.; Rossi, G. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗